Employers find a workaround for high GLP-1 costs, helping workers pay for semaglutide outside of...
Ongoing education is key for myeloma treatment advances, with therapies rapidly evolving in recent years.
Vibegron persists in 60% of OAB patients after one year according to a new study....
Hepatitis C cure rates lag despite effective treatments. Dr. Terrault highlights that one-third of infected...
New research links sputum color in bronchiectasis to airway inflammation and drug response, offering a...
New research links migraine treatment with monoclonal antibodies to a higher miscarriage risk during early...
Older AML patients now prioritize curability over fitness in treatment, as doctors shift focus to...
The FDA approved bepirovirsen for chronic HBV treatment, marking the first antisense oligonucleotide for this...
Targeted therapies are offering new hope for myasthenia gravis patients by addressing treatment gaps and...
The new stroke rehabilitation guidelines urge clinicians to begin therapy within 48 hours of admission,...